ARCHIVES

Still Misperceptions On Hill About CRADA Between NCI, BMS

This article is from The Cancer Letter archive.

Vol. 18 No. 11 | March 13, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: NCCS to hold Candlelight Vigil Sept. 25; Moffit Wins Chemistry-Biology Grants

September 17, 1999

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

In Brief: Last Two NCAB Choices Named; Hellman Heads ASCO, Sartorelli Named President Of AACR

May 16, 1986